8-K - Invivyd, Inc. (0001832038) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Invivyd filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
Directly affected
- IVVD Invivyd
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Invivyd belongs to, so it often moves with news about it.
- AMGN Amgen
Amgen is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences
Gilead Sciences is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna
Moderna is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE
argenx SE is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| IVVD | +2.87% | +2.56% | base | after close | after close | after close | after close |
| XLV | -0.28% | +0.04% | base | after close | after close | after close | after close |
| AMGN | -0.08% | +0.56% | base | after close | after close | after close | after close |
| GILD | +0.80% | +0.98% | base | after close | after close | after close | after close |
| MRNA | +20.51% | +11.41% | base | after close | after close | after close | after close |
| ARGX | +0.34% | +1.85% | base | after close | after close | after close | after close |
| RVMD | +16.24% | +4.86% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-16 AccNo: 0001193125-26-462025 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 16 Nov 2026: Invivyd (IVVD) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Amgen (AMGN) | three days earlier | +0.56% | final price |
| Amgen (AMGN) | five days earlier | -0.08% | final price |
| Argenx Se (ARGX) | three days earlier | +1.85% | final price |
| Argenx Se (ARGX) | five days earlier | +0.34% | final price |
| Gilead Sciences (GILD) | three days earlier | +0.98% | final price |
| Gilead Sciences (GILD) | five days earlier | +0.80% | final price |
| Invivyd (IVVD) | three days earlier | +2.56% | final price |
| Invivyd (IVVD) | five days earlier | +2.87% | final price |
| Moderna (MRNA) | three days earlier | +11.41% | final price |
| Moderna (MRNA) | five days earlier | +20.51% | final price |
| Revolution Medicines (RVMD) | three days earlier | +4.86% | final price |
| Revolution Medicines (RVMD) | five days earlier | +16.24% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +0.04% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -0.28% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 3 Nov 2026. That is 13 days before publication. Filed 12 Nov 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 32 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 55 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Moderna (MRNA), worth $1,001 - $15,000 on 20 Oct 2026. That is 27 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 73 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 27 Oct 2026. That is 20 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $1,001 - $15,000 on 15 Oct 2026. That is 32 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Argenx Se (ARGX), worth $15,001 - $50,000 on 14 Oct 2026. That is 33 days before publication. Filed 10 Nov 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Invivyd, Inc. (0001832038) (Filer)”
Companies mentioned with this story
- IVVD Invivyd
In “8-K - Invivyd, Inc. (0001832038) (Filer),” Invivyd (IVVD) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> IVVD
- XLV Select Sector Spdr Tr
In “8-K - Invivyd, Inc. (0001832038) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR holds the health sector that Invivyd belongs to, so it often moves with news about it
- AMGN Amgen
For “8-K - Invivyd, Inc. (0001832038) (Filer),” Amgen (AMGN) is linked, with no stored direction, medium confidence. Reason on file: Amgen is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news
- GILD Gilead Sciences
Gilead Sciences (GILD) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Invivyd, Inc. (0001832038) (Filer).” Reason on file: Gilead Sciences is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news
- MRNA Moderna
Moderna (MRNA) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Invivyd, Inc. (0001832038) (Filer).” Reason on file: Moderna is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news
- ARGX Argenx Se
For “8-K - Invivyd, Inc. (0001832038) (Filer),” Argenx Se (ARGX) is linked, with no stored direction, medium confidence. Reason on file: argenx SE is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news
- RVMD Revolution Medicines
Revolution Medicines (RVMD) is linked, with no stored direction, medium confidence in the 16 Nov 2026 story “8-K - Invivyd, Inc. (0001832038) (Filer).” Reason on file: Revolution Medicines is a peer of Invivyd in biological products, (no diagnostic substances); rivals often move on the same news
How “8-K - Invivyd, Inc. (0001832038) (Filer)” reaches Invivyd (IVVD)
“8-K - Invivyd, Inc. (0001832038) (Filer)” (16 Nov 2026) reaches Invivyd (IVVD) through this story.
What ties Invivyd (IVVD) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> IVVD
Select Sector Spdr Tr (XLV) is here too. Its reason reads: Health Care Select Sector SPDR holds the health sector that Invivyd belongs to, so it often moves with news about it
Dates and price levels for Invivyd (IVVD)
AMGN traded between 424.75 and 482.71 across 20 sessions. The latest close on file is 466.99.
How strong the case is around Invivyd (IVVD)
46 out of 100
“8-K - Invivyd, Inc. (0001832038) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.